financetom
Business
financetom
/
Business
/
Brazilian brewer Ambev posts 11% fall in its quarterly profit
News World Market Environment Technology Personal Finance Politics Retail Business Economy Cryptocurrency Forex Stocks Market Commodities
Brazilian brewer Ambev posts 11% fall in its quarterly profit
Nov 3, 2024 3:27 PM

Oct 31 (Reuters) - Brazilian brewer Ambev ( ABEV )

reported an 11% drop in third-quarter net profit on Thursday, in

line with market forecasts, driven by higher tax outlays in its

home market.

The subsidiary of Anheuser-Busch InBev, the world's

largest brewer by volume, posted a profit of 3.57 billion reais

($619.5 million), while volumes slipped 0.6%.

"We remain focused on executing our commercial strategy and

are confident in our preparedness for the summer season in South

America", the company said.

Ambev's ( ABEV ) volumes in Brazil rose 1.3%, driven by a 3.4%

increase in non-alcoholic drinks, led by health and wellness

brands like Gatorade and Red Bull. Premium and super premium

beer brands, including Corona, Spaten, and Original, saw a

slight increase of 0.6%.

In South America, the overall 7.7% decline was influenced by

inflation in Argentina, which negatively impacted consumer

demand. However, positive performances in Bolivia and Chile

provided some offset.

Earnings before interest, tax, depreciation and amortisation

(EBITDA) grew by 7% to 7.06 billion reais, slightly surpassing

consensus forecast of 7.03 billion reais.

The brewer announced in August that Carlos Eduardo Lisboa

would become its chief executive next year, replacing Jean

Jereissati Neto who is moving to lead the company's Middle

Americas unit.

($1 = 5.7624 reais)

Comments
Welcome to financetom comments! Please keep conversations courteous and on-topic. To fosterproductive and respectful conversations, you may see comments from our Community Managers.
Sign up to post
Sort by
Show More Comments
Related Articles >
Johnson & Johnson-Protagonist Therapeutics Partnered New Psoriasis Pill Wins FDA Nod, Shakes Up Competition With AbbVie
Johnson & Johnson-Protagonist Therapeutics Partnered New Psoriasis Pill Wins FDA Nod, Shakes Up Competition With AbbVie
Mar 19, 2026
On Wednesday, the U.S. Food and Drug Administration (FDA) approved Icotyde (icotrokinra), an interleukin-23 (IL-23) receptor antagonist for moderate-to-severe plaque psoriasis in adults and pediatric patients 12 years of age and older. FDA Approves Icotyde for Plaque Psoriasis in Adults and Teens Icotyde was jointly discovered and is being developed pursuant to the license and collaboration agreement between Protagonist Therapeutics,...
Electra Edges Lower, Near 52-Week Lows After Construction Update on North America's Only Cobalt Sulfate Refinery
Electra Edges Lower, Near 52-Week Lows After Construction Update on North America's Only Cobalt Sulfate Refinery
Mar 19, 2026
08:26 AM EDT, 03/19/2026 (MT Newswires) -- Electra Battery Materials Corporation ( ELBM ) , a North American critical minerals refining company, was edging lower and near 52 week lows in US premarket trade Thursday as it provided a construction progress update for its cobalt sulfate refinery project in Ontario. In a statement, it said the project continues to advance...
i-80 Gold Prices $250 Million Convertible Notes Offering
i-80 Gold Prices $250 Million Convertible Notes Offering
Mar 19, 2026
08:24 AM EDT, 03/19/2026 (MT Newswires) -- i-80 Gold ( IAUX ) said Thursday that it has priced an offering of unsecured convertible senior notes due 2031 worth $250 million, or $287.5 million if the option granted initial purchasers to purchase additional notes is fully exercised. The offering was upsized from a previously announced $200 million, the company said. The...
Taysha Gene Therapies 2025 Net Loss Narrows, Revenue Rises
Taysha Gene Therapies 2025 Net Loss Narrows, Revenue Rises
Mar 19, 2026
08:28 AM EDT, 03/19/2026 (MT Newswires) -- Taysha Gene Therapies ( TSHA ) reported 2025 net loss Thursday of $0.34 per diluted share, narrowing from a loss of $0.36 a year earlier. Analysts polled by FactSet expected a loss of $0.37. Revenue for the year ended Dec. 31 was $9.8 million, up from $8.3 million a year earlier. Analysts surveyed...
Copyright 2023-2026 - www.financetom.com All Rights Reserved